Atripla
Gilead Sciences Proceeds with $247 Million Settlement in HIV Antitrust Case Following Trial Victory
Anika Sharma
Despite Gilead Sciences and Teva Pharmaceutical Industries emerging victorious in a high-stakes antitrust trial related to HIV drugs earlier this ...
